Cite
HARVARD Citation
Moonesinghe, K. et al. (2017). What is the appropriate dose for spironolactone as a fourth‐line agent in treating resistant hypertension?. Evidence-based practice. 20 (6), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moonesinghe, K. et al. (2017). What is the appropriate dose for spironolactone as a fourth‐line agent in treating resistant hypertension?. Evidence-based practice. 20 (6), p. . [Online].